Charlotte Boughton

Has grant

Clinical Lecturer

University of Cambridge

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Charlotte Boughton is a Clinical Lecturer at the University of Cambridge, UK. Her research primarily focuses on automated insulin delivery systems, exploring the early stages, challenges, and cost-effectiveness of these technologies, particularly in children and adolescents with Type 1 diabetes. Recent publications highlight her contributions to the understanding and implementation of closed-loop insulin delivery systems and their integration into clinical care.

Recent Grants

Grant: Close

Closed-loop insulin delivery for people living with Cystic Fibrosis related diabetes

Open Date: 2022-05-01

Close Date: 2024-08-01

Grant: Close

Fully closed-loop insulin delivery for inpatients with diabetes.

Open Date: 2021-09-01

Close Date: 2022-09-01

Grant: Close

Fully closed-loop insulin delivery for inpatients with diabetes.

Open Date: 2020-11-01

Close Date: 2021-08-01

Grant: Close

Implementation of fully closed-loop insulin delivery for inpatients with diabetes.

Open Date: 2020-04-01

Close Date: 2022-04-01

Grant: Close

Closed-loop insulin delivery in adults with type 2 diabetes receiving haemodialysis

Open Date: 2018-06-01

Close Date: 2019-06-01

Articles (28)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (9)

Michael Hughes

Assistant Professor of Medicine

Emory University

UNITED STATES

View details

Rachel Besser

Honorary senior clinical lecturer

UNITED KINGDOM

View details

Hood Thabit

Consultant Diabetologist and Honorary Senior Lecturer

Manchester University NHS Foundation Trust

UNITED KINGDOM

View details

Michael Riddell

Professor

York University

CANADA

View details

Julia K. Mader

Medical University of Graz

AUSTRIA

View details

Mark Evans

Professor of Diabetic Medicine/ Honorary Consultant Physician

Cambridge University Hospitals

UNITED KINGDOM

View details

Roman Hovorka

Professor of Metabolic Technology

University of Cambridge

UNITED KINGDOM

View details

Paul Wadwa

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Lalantha Leelarathna

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Charlotte Boughton

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (28)

Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems

Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems

Early Stages of Automated Insulin Delivery

Early Stages of Automated Insulin Delivery

Successful use of a fully closed-loop insulin delivery system in an adolescent with diabetes secondary to pancreatitis – a case report

Toward Automation: The Road Traveled and Road Ahead for Integrating Automated Insulin Delivery into Inpatient Care

Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial

Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 Diabetes

Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial

The effect of closed-loop glucose control on C-peptide secretion in youth with newly diagnosed type 1 diabetes: the CLOuD RCT

Safety of Options to “Boost” (Enhancing Insulin Infusion Rates) and “Ease-Off” (Reducing Insulin Infusion Rates) in CamAPS FX Hybrid Closed-Loop System: A Real-World Analysis

Contrasting Glycemic Outcomes in Young People with Diabetic Ketoacidosis at Onset of Type 1 Diabetes

The role of automated insulin delivery technology in diabetes

Lived Experience of Fully Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes

Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 Diabetes

Eighteen-Month Hybrid Closed-Loop Use in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Trial

Impact of the CamAPS FX hybrid closed‐loop insulin delivery system on sleep traits in older adults with type 1 diabetes

Closed-Loop from Diagnosis of Type 1 Diabetes in Children and Young People

Time spent in hypoglycemia according to age and time-of-day: Observations during closed-loop insulin delivery.

Patient‐reported outcomes for older adults on CamAPS FX closed loop system

Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover Study

Hybrid Closed-Loop with Faster Insulin Aspart Compared with Standard Insulin Aspart in Very Young Children with Type 1 Diabetes: A Double-Blind, Multicenter, Randomized, Crossover Study

Variability of Insulin Requirements in Adults with Type 2 Diabetes During Fully Closed-Loop Insulin Delivery

Implementation of fully closed‐loop insulin delivery for inpatients with diabetes: Real‐world outcomes

Insulin Requirements Over Eight Weeks of Fully Closed-Loop Insulin Delivery in Adults With Type 2 Diabetes

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial

Evaluating the Impact of Applying Personal Glucose Targets in a Closed-Loop System for People With Type 1 Diabetes.

Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm.

Collaborators (9)

Michael Hughes

Rachel Besser

Hood Thabit

Michael Riddell

Julia K. Mader

Mark Evans

Roman Hovorka

Paul Wadwa

Lalantha Leelarathna

Make your next move.